Manulife appointed Mike Durland and Don Kanak to its Board of Directors, effective March 5, 2024. Mr. Durland is a former senior executive at The Bank of Nova Scotia, holding a number of senior roles in their capital markets division, including Group Head and CEO, Global Banking and Markets. He is currently the Chief Executive Officer of Melancthon Capital Corporation, a private company primarily focused on the provision of capital and advisory services to emerging Canadian companies. He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University. Mr. Kanak is a former senior executive with deep insurance experience in Asia. Most recently, he held several senior roles with Prudential Holdings Ltd. (part of Prudential plc.). He ultimately served as Chairman, Insurance Growth Markets and Chairman, Prudence Foundation and, prior to that, Chairman, Eastspring Investments and Chairman of Prudential Corporation Asia. He served in senior executive positions at American International Group (AIG) for over 14 years before joining Prudential. He holds a Bachelor of Arts from the University of North Carolina, a JD from Harvard Law School, and a MLitt from Oxford University in management studies. Ms. Manning is the former President and Chief Executive Officer of Reinsurance Group of America, Incorporated (RGA), a global reinsurance company focusing on life and health solutions. Prior to joining RGA, she spent 19 years with the Toronto office of Towers Perrin's Tillinghast insurance consulting service, providing consulting services to the insurance industry on mergers and acquisitions, value-added performance measurement, product development, and financial reporting. She is a Fellow of the Society of Actuaries and the Canadian Institute of Actuaries Science from the University of Toronto. Mr. Wong is a former Senior Partner and the former Chairman of GreaterChina for Boston Consulting Group, where he currently serves as a Senior Advisor. He is a trusted consultant with over 30 years of experience serving global clients in the Asian healthcare market and a deep expertise in building businesses in biopharmaceuticals, medical technology, and consumer health. Mr. Wong holds an MBA from Harvard University, an M.Sc. in Chemical Engineering from the Massachusetts Institute of Technology, and B.Sc. in Chemical Engineering from Imperial College London. Mr. Durland
joins the Board's Audit Committee and Corporate Governance and Nominating Committee and Mr. Kanak joins the Management Resources and Compensation Committee and Risk Committee.